Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print December 26, 2003.
Biol Reprod 2003, 10.1095/biolreprod.103.023283
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
70/5/1270    most recent
biolreprod.103.023283v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T.-C.
Right arrow Articles by Liu, J.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T.-C.
Right arrow Articles by Liu, J.-Y.
Agricola
Right arrow Articles by Cheng, T.-C.
Right arrow Articles by Liu, J.-Y.
Submitted September 15, 2003
Returned for revision October 9, 2003
Accepted December 15, 2003

Embryo


Leukemia Inhibitory Factor Antisense Oligonucleotide Inhibits the Development of Murine Embryos at Preimplantation Stages

Tzu-Chun Cheng , Chun-Chia Huang , Chung-I Chen , Chung-Hsien Liu , Yih-Shou Hsieh , Chih-Yang Huang , Maw-Sheng Lee , and Jer-Yuh Liu *

* To whom correspondence should be addressed. E-mail: jyl{at}csmu.edu.tw.

Abstract
Leukemia inhibitory factor (LIF) is an essential factor for implantation and establishment of pregnancy. However, its role in the development of pre-implantation embryos remains controversy. In this study, changes in pre- implantation embryos were determined after microinjection of LIF antisense oligonucleotide at the two-pronucleus stage. Although no significant differences were found in the percentages between the untreated group and the 0.25- fmol treated group, the 0.5- or 1.0-fmol treated groups had significantly lower percentages of embryos developed to the morula or blastocyst stage and the 2.0-fmol treated group had significantly lower percentages of embryos developed to the four-cell, morula, or blastocyst stage. No embryos developed to the four-cell stage in the 4.0-fmol treated group. Moreover, there was a decreasing trend in the levels of LIF immunoactivity with the increasing amount of LIF antisense oligonucleotide injected. The diameter of blastocysts in the 2.0-fmol treated group was significantly smaller than that in the untreated group. The blastocysts in this group had significantly lower numbers of blastomeres and cells in the inner cell mass (ICM) or trophetoderm (TE) and ICM/TE ratio. The 1.0- or 2.0-fmol treated groups had significant lower implantation rates than their corresponding control groups. In the 2.0-fmol groups with supplementing exogenous LIF, significantly lower percentages were also observed in the four-cell, morula, and blastocyst stages. However, blastocysts treated with 50 ng/ml LIF had a significant higher percentage than those in the LIF gene impaired group without LIF supplement. These results indicate that LIF is a critical factor for the normal development of embryos at the pre- implantation stages.

Key words: Embryo • Cytokines • Developmental biology • Early development • Growth factors


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
W. V. Ingman and R. L. Jones
Cytokine knockouts in reproduction: the use of gene ablation to dissect roles of cytokines in reproductive biology
Hum. Reprod. Update, March 1, 2008; 14(2): 179 - 192.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. J Kimber
Leukaemia inhibitory factor in implantation and uterine biology
Reproduction, August 1, 2005; 130(2): 131 - 145.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. Nie, Y. Li, M. Wang, Y. X. Liu, J. K. Findlay, and L. A. Salamonsen
Inhibiting Uterine PC6 Blocks Embryo Implantation: An Obligatory Role for a Proprotein Convertase in Fertility
Biol Reprod, April 1, 2005; 72(4): 1029 - 1036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2003 by the Society for the Study of Reproduction.